Histopathological classification of hepatocellular carcinoma

Digestive and Liver Disease

Volumn 42, Issue SUPPL. 3, 2010, Pages S228-S234

  Roncalli, Massimo ^a   Park, Young Nyun ^b   Di Tommaso, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Dysplasia; Early progressed HCC; Hepatocarcinogenesis; Stem progenitor cell

Indexed keywords

BIOLOGICAL MARKER; GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN 70;

ADVANCED CANCER; ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER MORPHOLOGY; CANCER STEM CELL; EARLY CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MIXED TUMOR; PRIORITY JOURNAL; CELL DIFFERENTIATION; CLASSIFICATION; DISEASE COURSE; LIVER CELL; LIVER TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL;

CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DISEASE PROGRESSION; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; STEM CELLS;

EID: 77953694704     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(10)60510-5     Document Type: Article

References (33)

1. Boyault S, Rickman DS, de Reyniès A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007, 45:42-52.
2. Katoh H, Ojima H, Kokubu A, et al. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology 2007, 133:1475-1486.
3. Llovet JM, Bruix J Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008, 48:1312-1327.
4. Farazi PA, DePinho RA Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006, 6:674-687.
5. Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993. International Working Party.
6. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009, 49:658-664. International Consensus Group for Hepatocellular Neoplasia The International Consensus Group for Hepatocellular Neoplasia.
7. Borzio M, Fargion S, Borzio F, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003, 39:208-214.
8. Libbrecht L, Bielen D, Verslype C, et al. Focal lesions in cirrhotic ex-plant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002, 8:749-761.
9. Kojiro M, Roskams T Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005, 25:133-142.
10. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
11. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninva-sive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
12. Park YN, Kojiro M, Di Tommaso L, et al. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 2007, 109:915-923.
13. Di Tommaso L, Franchi G, Park YN, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
14. Di Tommaso L, Destro A, Seok JY, et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009, 50:746-754.
15. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998, 28:1241-1246.
16. Ng IO, Guan XY, Poon RT, et al. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003, 199:345-353.
17. Durnez A, Verslype C, Nevens F, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006, 49:138-151.
18. Uenishi T, Kubo S, Yamamoto T, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sei 2003, 94:851-857.
19. Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepato-cellular carcinoma metastasis. Mol Cell Proteomics 2004, 3:73-81.
20. Yamashita T, Forgues M, Wang W, et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 2008, 68:1451-1461.
21. Ma S, Chan KW, Hu L, Lee TK, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
22. Wu P, Fang J, Lau V, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: clinical and biological implications. Am J Pathol 1996, 1167-1175.
23. Yoon DS, Jeong J, Park YN, et al. Expression of biliary antigen and its clinical significance in hepatocellular carcinoma. Yonsei Med J 1999, 40:472-477.
24. Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-1024.
25. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006, 12:410-416.
26. Budhu A, Chen Y, Kim JW, et al. Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis 2007, 28:1552-1560.
27. Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008, 359(19):1995-2004.
28. Hoshida Y, Nijman SM, Kobayashi M, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 2009, 69:7385-7392.
29. Theise ND, Yao JL, Harada K, et al. Hepatic " stem cell" malignancies in adults: four cases. Histopathology 2003, 43:263-271.
30. Fujii T, Zen Y, Harada K, et al. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma-human and cell culture study. Hum Pathol 2008, 39:1185-1196.
31. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004, 40:298-304.
32. Shiota K, Taguchi J, Nakashima O, et al. Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep 2001, 8:263-268.
33. Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008, 47:1544-1556.